Professional Documents
Culture Documents
GMP Fundamental.....
GMP Fundamental.....
GMP Fundamental.....
Introduction Documentation
Equipment Validation
Personnel API
Opening Message Material
Introduction Documentation
Equipment Validation
Personnel API
Opening Message Material
Introduction Documentation
Equipment Validation
Personnel API
What is GMP?
e.g.
Contamination, Cross contamination
Mix-ups
GMP
Pharmaceutical/
Biologicallyderived
products
Medical devices ………….
Opening Message Material
Introduction Documentation
Equipment Validation
Personnel API
GMP Scope
Already discussed by
Sultan Ghani Saheb
C in cGMP
Adequate documentation/records
Quality control/assurance
Validation
Equipment calibrated/qualified
Introduction Documentation
Equipment Validation
Personnel API
Premises
Principle
Neighbours
What do they do?
What impact can they have on the business?
Pollution/effluent control
Premises
Facilitate sanitation.
Be maintained and cleaned easily
Services availability
Protection against entry of insects or other
animals
Premises
Ancillary Areas
Maintenance workshops
Animal houses
Premises
Design Principles
Process flow
Material flow
People flow
Premises
Warehouse
Storage areas of sufficient capacity for
Clean, dry and maintained within
acceptable temperature limits
Area under cover, protection from heat,
dirt, and rain
Areas clearly marked and access limited
for quarantine status good.
Premises
Warehouse
Storage areas of sufficient capacity for
Weighing areas
Control systems
Segregation
Interior surfaces
smooth/crack-free/easy to clean
Premises
Other Areas
Personnel rest
areas/cafeterias/changing rooms:
away from operating areas
prevention of cross-contamination
prevention of operators going outside in
work clothes
provision of access control
prevention of visitors access to operating
areas
Premises
Other Areas
Maintenance service areas:
separated from production areas
whenever possible
Cross-contamination
1. Segregated areas
2. Airlocks and pressure differentials
3. Treatment of recirculated air
4. Protective clothing
5. Effective cleaning procedures
6. Closed production systems
7. Residue testing
8. Status labelling
Premises
Drain design:
equipped to prevent backflow
open channels avoided
Prevention of cross-contamination
Introduction Documentation
Equipment Validation
Personnel API
Equipment
Equipment
must be:
-located
-designed
-calibrated
-monitored
-maintained
Equipment:
Instrument Calibration
Frequency based on:
-Nature/type of equipment
-Type/frequency of use
-Importance of measurement
Equipment: Monitoring
-documented
-Use log
-traceability
Equipment
Equipment: Maintenance
Preventative
Scheduled and based on SOPs &
usage
Corrective
Malfunction/breakdown
Documented
Maintain log books near equipment
and available
Equipment
Types of equipment
maintenance
Non-scheduled maintenance
Performed as needed (in cases where
equipment malfunctions/breaks down)
Equipment:
Modifications/Changes
Corrective or planned (maintenance
or for improvement)
Evaluated (may require revalidation)
Approved
Documented
Effective date noted
Equipment
Possible Issues
-Poor design
-Lack of safety
-Poor quality finishes
-Lack of cleaning
-Lack of maintenance
-No usage log or record
-Use of inappropriate weighing
equipment
-Open-plan location of
compressing machines
Opening Message Material
Introduction Documentation
Equipment Validation
Personnel API
Personnel
Personnel
Personnel
People are the most critical element
in ensuring the quality of the
product – and that the application of
Good Manufacturing Practices
Training
Company organization, policies, etc.
Job function
Maintenance
Regulatory Interpretation
5 interpretations
-Required qualifications of manufacturers,
packagers/labelers/testers in charge of
manufacturing and quality control
departments
Regulatory Interpretation
5 interpretations (cont’d)
Possible Issues-I
-Inadequate experience
Possible Issues-II
-Illness
Opening Message Material
Introduction Documentation
Equipment Validation
Personnel API
Material
Principle
Objective of the pharmaceutical
manufacturer:
-To produce finished products from a
combination of materials
Materials combined:
-Active Pharmaceutical Ingredients
-Auxiliary Materials(excipients)
-Packaging Materials
Material
Starting Materials-I
Things to consider;
Purchasing of starting material
Suppliers of starting material
Delivery of starting material
Integrity
E.g. damaged containers
-seal
-order
-delivery note
-Supplier’s labels
Material
Starting Materials-II
Things to consider;
Cleaned and labelled
-name and internal code
-batch number(s), (supplier &
manufacturer on receipt)
-status
-expiry date or re-test date
Sampled containers identified
Material
Starting Materials-III
Use only released material
Dispensing:
-designated persons
-written procedure
-accurately weighed
-clean, labelled containers
Independent checks
-material and weight
Dispensed material:
-kept together and labelled
Material
Packaging Materials-I
Packaging Materials-II
Appropriate conditions
Purchased:
-as starting materials
Material
Finished Products
Storage conditions
Reagents
Reference Standards
Official reference standards
-use only as per monograph
-storage
Reference standards prepared by the
producer:
-tested, released
-stored in same way as official reference
standards
Secondary or working standards:
-appropriate checks and tests
-regular intervals
-based on official reference standards
Opening Message Material
Introduction Documentation
History and Background Complaints and Recalls
Equipment Validation
Personnel API
Documentation
And then….
PROVE IT”
Documentation
What is proof?
DOCUMENTED EVIDENCE
“proof is evidence that tends to
establish the existence of a fact”
-Records
Who is involved?
Anyone and everyone implicated in
any of the procedures noted
Why Document?
-to ensure that there are specifications for
all materials and methods of manufacture
and control
Document Hierarchy?
Procedural SOPs
-Detailed work instructions
Records of Work
-Forms
-Logs
Documentation
Types of Documentation
Written Standards
-SOPs and Specifications (RM, pkg)
-Protocols (validation)
Blank Templates
-QC worksheets, log books, cleaning logs,
etc.
Documentation
Types of Documentation
Records
Completed templates (BPR)
Product protocols
-All relevant records for review and release
Reports
-Validation, audit, non-conformity, product
review/trending
-Signature verification
-Personnel training
Documentation
Written Instructions
How to do something
-Describe WHAT is actually done
Performance/standards of
performance
To ensure consistency
Documentation
Authorized document
-Supervisors/Managers?
-Consultants
-QA
-Technical Staff?
Documentation
SOP Format
SOP Format
SOP Format
Identification & Control: SOP number and revision
1 QP - 001 - 02
-1 = Volume (dept. specific)
1 = QA, 2 = QC, 3 = RA, 4 = Filling
SOP Format
-Text Style
-Active verbs/direct statements
-Relevant procedures
-Simple wording
-Clear and concise
Can it be understood, will it be followed?
Focus on WHAT is to be done
Documentation
SOP Format
Organization
-Beginning
Title, introduction & lists (equipment,
materials, people)
-Body
procedures
-End
References, attachments/appendices
Documentation
SOP Format
Organization: Beginning
SOP Format
Organization: Body
Incubate
SOP Format
Organization: End
-References
-Internal (other SOPs or documents)
-External (regulations, technical papers, etc.)
-Attachments/Appendices
Attach complex tables, flow charts, blank forms or
other blank documents, copies of completed
documentation, etc.
Documentation
RECAP
-Printing
-Authorizations
Departmental
QA/RA
-Distribution and document control
-Life span
-Annual reviews/revisions
Documentation
-QA Authorization
-Single QA review by the relevant QA auditor
Document Control:
-Makes copies
-Applies official stamp
-Distributes copies
Only “official” stamped copies can be
used?
Documentation
Life Span
-SOPs generally last for 2 years
Based on effective date
Revisions
-If changes have occurred, the SOP must be revised
Regardless of the ”expiry date” of the SOP
Revisions
-The old SOPs are recalled and destroyed
-All documentation is retained FOREVER
All previous SOP editions, review forms and
supporting documentation
-Common problems
Real citations
7 deadly sins
Non-Concurrent Entries
-Hard to find
Documents filled in before the event
Documents filled in after the event
Missing Information
-Signatures/initials
-Dates/times (am/pm)
-Information/explanations
Forgotten Entries
Blank Areas
Improper Corrections
-The “scribbler”
Documentation
Illegible Writing
Prevention
-Training
-Restrict access
Inconsistencies
Prevention
-Policy SOP
Clear standards of performance
-Training
-Adequate resources
-Ensures consistency
Clear procedures for documentation
Suggest to include:
-Scope (types of records)
-Basics (pens, legibility, completeness, concurrent,
data/time formats, etc.)
-Dealing with problems (making corrections and
non-concurrent entries)
-Record reviews
-Record keeping, retention & retrieval
Documentation
-Control of
Written standards
Blank templates
Work records/reports
Documentation
Document Control
-Writing/updating
Change control
Any System
-Policy SOP
Clear standards of performance
Responsibilities clear
-Procedure SOPs
-Standard Forms
Easy to fill out
checklists
Documentation
Change Control
Summary
Introduction Documentation
Equipment Validation
Personnel API
Complaints
Complaints
-General comments & questions
Unrelated to product quality (late delivery)
-Adverse events
Side effects (expected and unexpected)
pharmacovigilance
Complaints
Complaints
Why does a Company Respond?
-Regulatory requirement (due diligence)
-REPUTATION
Complaints
Complaints
Complaints
Elements
-Defined program
Designated complaint handling unit
Written procedure
-Complaint documentation
Logs and reporting forms
Complaints
Complaints
Elements (cont’d)
-Regulatory Review
-Investigation
Returned product review
-Customer follow-up
-Trending
Complaints
Policy SOP
Departments and responsibilities
Classifications
Time limits for procedures
Specifications for reporting to regulatory authorities
Complaints
Complaint Documentation
RA/ QA Review
Minor/major/critical
Dependent on the drug involved
Parenteral example;
Minor: redness/swelling at injection site
Major: fever & convulsions
Critical: death
Complaints
Root cause ID
Time limits for completion
Testing
Auditing
Records and/or process
Complaints
Monitoring of Progress
Decisions/ Actions
• Nothing thru to recall
Recalls
Recalls
Removal of product from the market
Due to quality, safety, efficacy, etc. problems.
Suspected or confirmed
Reduce/remove risk/hazard to consumers
Regulatory requirement
Recalls
Mandatory
Quality/safety risk
Labeling problems (#1)
Stability failures (dissolution testing)
Sterility/contamination
Recalls
Recalls
Voluntary
Potential risk
-Complaint but not a hazard
-Asthetic issues
Recalls
Recalls
System Requirements (C.02.012)
-Prompt action
Recalls
Formal Plan
-Communication requirements
Recalls
Communication
-Regulatory Agency
Informed early
Review of plan and letters
Recalls
-Detailed documentation of every vial, bottle,
tablet/capsule, device, etc
Who received what, how much and when
Manufacturer, wholesaler, importer and distributor records
Customer level: print or media notices
Health Canada alerts to Doctors, Pharmacists, etc
Recall Process
-Monitoring
Close scrutiny by the regulatory bodies
Clear documentation requirements
Enforcement action (inspections) may result
-Closure
Return of all product possible
Complete documentation & destruction
Final report prepared
Recalls
Summary: Recalls
Introduction Documentation
Premises
Sanitation and
Hygiene
Equipment Validation
Personnel API
Sanitation and Hygiene
Scope
Design of Premises
Design
Walls, floors, ceilings, ledges, drains, air supply, dust
extraction
Design of Premises
Effective cleaning and disinfection
choice of materials and chemicals, validation
Drains
Avoidance of Cross-contamination-I
-Segregated areas
-Ventilation systems and airlocks
-Clothing
-Closed processing systems
-Cleaning and decontamination
Sanitation and Hygiene
Avoidance of Cross-contamination-II
-penicillin products
Sanitation and Hygiene
Avoidance of Cross-contamination-III
Ventilation systems
Avoidance of Cross-contamination-IV
Clothing
-protection of operator and product
Avoidance of Cross-contamination-V
Avoidance of Cross-contamination-VI
Simultaneous operations
-not permissible to process different products in different
areas with a common ventilation system
Process of checking
-all materials and documentation from the previous batch removed
-checklist useful
Sanitation and Hygiene
-Final rinse with purified water, or water for injection (for sterile
products)
-Area clearance by QC
Sanitation and Hygiene
Personal Hygiene-I
Health examinations
On recruitment for direct operators , repeated on regular basis
Training - check
induction training for new operators includes basic personal hygiene
training
Personal Hygiene-II
Illness
staff with illness or open lesions should not handle starting materials,
intermediates or finished products
Adverse conditions
operators trained to recognize risks
willingness to report illness to the area supervisor
Sanitation and Hygiene
Personal Hygiene-III
Personal Hygiene-IV
-Smoking, eating and drinking should not be allowed in any
manufacturing area, including laboratories and storage rooms.
Introduction Documentation
Equipment Validation
Personnel API
Validation
Definition
-Revalidation
Periodic revalidation
Revalidation after change
Validation
Stages of Validation
Existing
Start with major processes, equipment
Types of Documentation
Protocol
Report
-Title
-Objective of the study
-Refer to the protocol
-Details of material
-Equipment
-Programmes and cycles use
-Details of procedure and test methods
Validation
Possible situation-I
-Ventilation system
Equipment and process
Training
Validation
Possible situation-II
Possible situation-III
A new liquids manufacturing building on an existing site
which will produce 2 products.
-Ventilation
-Equipment and process
-Cleaning
-Training
Validation
Possible situation-IV
An existing sterile suite producing 5 products that are
terminally sterilized
-Sterilizers
-Ventilation and other environmental aspects
-Equipment and process
-Cleaning
-Training
Opening Message Material
Introduction Documentation
Equipment Validation
Personnel API
Active Pharmaceutical Ingredients
General Considerations
-Overall control
-Consistent uniform batches
-Compliance with GMP
production
quality control
-General guidelines
-Co-operation in production
-Human and veterinary preparations
Active Pharmaceutical Ingredients
Personnel
-Qualified and competent
production and quality control
sufficient number
education, knowledge, experience
Premises
General
-suitable construction and environment
-mix-ups or contamination
Premises
Hygiene
Equipment
Cleaning
sterilised, used, maintained: SOPs, records and checks
Active Pharmaceutical Ingredients
Equipment
Defective equipment
removed or labelled
repaired, documented
Active Pharmaceutical Ingredients
Sanitation
-Written programmes
validated for premises and equipment
quality standard for water
hygiene , health and clothing practices
waste disposal
Documentation
Master formulae
written instructions
master formula contents
authorisation
outdated documents
amendments
Batch documentation
batch manufacturing record contents
contract production
data recording
Active Pharmaceutical Ingredients
Production
Processing procedures
-master formula
-critical steps defined and validated
-supervision
-labelling
vessels, containers, equipment
Active Pharmaceutical Ingredients
Production (continued)
Starting materials
receiving, quarantine, sampling
testing
release, reject, storage, labelling
dispensing SOP
exceptions for hazardous materials
Intermediates
testing
labelling
storage
Active Pharmaceutical Ingredients
Production (continued)
Production (continued)
Packaging
-packaging material selection
-procedures to prevent error
-labelling, including:
Product name
Quality
Batch number
Expiry or retest date
Warnings, if required
Storage conditions
Names of manufacturers and suppliers
Active Pharmaceutical Ingredients
Quality Control
Independent unit
Duties: Approve, reject or release
specifications and methods
sampling, sanitation and hygiene
reprocessing
stability
complaints
Laboratory access and requirements
Contract laboratories
Active Pharmaceutical Ingredients
Stability Studies
Written programme
stability indicating methods
Samples
containers
storage conditions
Records
Active Pharmaceutical Ingredients
Storage
Reject materials
Written procedures
starting materials, intermediates, packaging materials
identified
storage pending fate
Active Pharmaceutical Ingredients
Possible Issues
Hazardous processes
Commercial secrecy
Possible Issues